Skip to main content
ALEMBIC PHARMACEUTICALS LIMITED logo

ALEMBIC PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · APLLTD ISIN · INE901L01018 LEI · 335800PM173KNG818V30 BSE.NS Manufacturing
Open in API
Filings indexed 1,367 across all filing types
Latest filing 2026-05-25 Regulatory Filings
Country IN India
Listing BSE.NS APLLTD

About ALEMBIC PHARMACEUTICALS LIMITED

https://www.alembicpharmaceuticals.com

Alembic Pharmaceuticals Limited is a vertically integrated pharmaceutical organization engaged in the development, manufacturing, and marketing of generic pharmaceutical products, active pharmaceutical ingredients (APIs), and formulations. Established in 1907, the company operates advanced research and development centers and manufacturing facilities that adhere to international regulatory standards, including USFDA compliance. Its diverse product portfolio covers key therapeutic areas such as anti-infectives, cardiology, gynecology, gastrointestinal, and dermatology. Alembic maintains a strong global presence, supplying high-quality medications to markets in North America, Europe, and various emerging regions. The company prioritizes innovation through its focus on complex generics and specialty products, aiming to provide affordable and effective healthcare solutions worldwide.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is an intimation under SEBI LODR Regulation 30 notifying stock exchanges of the company’s participation in an investor conference and one-to-one meetings. It does not contain financial results, management changes, or the actual presentation materials, nor is it a formal annual/interim report or proxy statement. It is a miscellaneous regulatory announcement, best fitting the fallback category Regulatory Filings (RNS).
2026-05-25 English
Please find enclosed Intimation.
Regulatory Filings Classification · 80% confidence The document is a stock exchange intimation under SEBI LODR Regulation 30 about participation in an upcoming analysts/investors meeting. It contains no financial statements or substantive data, nor is it an actual presentation or report. It is a routine regulatory disclosure to the exchanges. Per the classification rules, this falls under General Regulatory Filings (RNS).
2026-05-25 English
Press Release
Regulatory Filings Classification · 75% confidence The document is a stock exchange filing by Alembic Pharmaceuticals Limited notifying the exchanges (BSE and NSE) of a regulatory event: USFDA final approval for a product. It is a press release style corporate announcement, not a financial report, not an annual or interim report, not a management or investor presentation, and not a prospectus or proxy. It falls under general regulatory announcements. Therefore, it best fits the Regulatory Filings category (RNS).
2026-05-22 English
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Levothyroxine Sodium Tablets USP.
Regulatory Filings Classification · 85% confidence The document is a press release filed with stock exchanges announcing USFDA final approval of a pharmaceutical product. It does not present financial statements, voting results, management changes, or capital transactions. It is a standard regulatory announcement to exchanges and falls into the fallback category for miscellaneous regulatory filings.
2026-05-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is titled “Transcript of Post Results Conference Call held on 15th May, 2026” and contains the full Q4 FY ’26 earnings conference call transcript, including management presentations and a Q&A session. This matches the definition of a Call Transcript (CT) filing.
2026-05-21 English
Please find attached.
Call Transcript Classification · 95% confidence The document is the full text transcript of Alembic Pharmaceuticals’ Q4 FY ’26 post-results earnings conference call held on May 15, 2026, including moderator and speaker Q&A. This matches the definition of a Call Transcript (CT).
2026-05-21 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.